KCC Referral
Management System
Shared Care
Guidelines
Care Home
Resources
Local Resource
Packs
Chronic Pain
in Cornwall
Diabetes Resources
Respiratory Resources
Flu Resource Pack
Patient Group Direction (PGD)
Palliative Care Resources
Search   
        Click to View ALL BNF
 >>  >> 
   (Click to View Drug List)


Cost
Packs
Items
Other - Cost: £689,881,567.99 Atorvastatin - Cost: £9,109,732.63 Apixaban - Cost: £10,281,388.69 Trimbow - Cost: £10,982,867.00 Beclometasone / Formoterol MDI (Fostair) - Cost: £13,118,588.96 Empagliflozin (Jardiance) - Cost: £13,893,150.23 Edoxaban (Lixiana) - Cost: £19,888,046.50 FreeStyle Libre 2 Sensor  - Cost: £20,225,625.00 Dapagliflozin (Forxiga) - Cost: £26,828,709.16
Formulary Notes (BNF Chapter)
NICE Guidance (13)
Other Links (3)
Important Local Documents (4)
Notes for: Skin
Last edited [24/06/2024 15:35:59]

Please ensure that patients using Epimax OintmentEpimax Paraffin-Free Ointment and Epimax Original Cream know that the product should not be used around the eyes or on the face. Furthermore, please advise to wash hands after use.

Please do not prescribe these products for use on the face.

If Epimax Ointment or Epimax Paraffin-Free Ointment is used around the eyes or on the face and accidentally comes into contact with the eyes, patients may present with unexplained ocular surface toxicity/ cell damage, consistent with mild ocular chemical injury.

Please see the Aspire Pharma field safety notice for further details 

 

Last edited [24/06/2024 15:36:37]

Emollient prescribing guidelines 2023

Bath emollients support document 2023

Moisture Associated Skin Damage (MASD) Pathway

Emollient pathway

Fire risk with emollients - advice to Health Care professionals

Management of skin conditions

With skin disease it is extremely important to consider patient acceptability of a product to maximise patient compliance. There is a wide range of products available and patient acceptance of individual products is very variable.

Where a consultant or GP with specialist interest asks a GP to prescribe a non-formulary agent they should check that formulary agents have been tried and not tolerated by the patient

Greasy preparations (ointments) are often preferable to creams in most circumstances because:

  • They contain fewer skin sensitisers
  • They are more hydrating (i.e. water retaining)
  • There is better penetration of active ingredients

However, patient preference or activity may necessitate a combination of ointments and creams, for example, patients may prefer to apply creams during the day and use ointments at night, or different preparations on different parts of the body.

Application technique: It is important to educate patients with the correct application technique. Ointments and creams should be applied down the direction of hair growth. They should also be smeared on and not rubbed in.

Pot Hygiene: When supplying patients with pots of emollient, it is important to educate them about the hygiene required. Patients should be advised to decant from the pot onto plate/bowl etc. using a spoon or a spatula. Hands should not be put into the pot as this will lead to the introduction of foreign particles.

In many cases generic prescribing will be difficult because products contain a combination of active ingredients. In this chapter brand names are used for products which should not be prescribed generically.

Extemporaneous preparations: A product should only be extemporaneously prepared when there is no product with a marketing authorisation available. Depending on the formulation this may be done in a pharmacy, or by a specials manufacturer, usually depending on the formulation. Where a specials manufacturer prepares the product, additional charges will be incurred. The cost can, and usually does, exceed £100 for a cream. The cost is usually the same whether 500 g or 50 g of a product is ordered. Specials all have a very short shelf life with an expiry date of a maximum of 28 days from manufacture.

A range (but not all) of specials preferred by the British Association of Dermatologists has been approved for use within Cornwall mainly for prescribing by secondary care. 

 

Cornwall Joint Formulary Recommended Choices     (...Top)
Displaying 12 Drugs

Key:
First Line Drugs First Line Drugs
Second Line Drugs Second Line Drugs
Specialist advised Specialist advised
Specialist Initiated Drugs Specialist Initiated Drugs
Hospital Only Drugs Hospital Only Drugs
Discouraged Discouraged
No comment available No comment available

NameTariffBNF Sub Paragraph
Calcipotriol Ointment (Dovonex / Calcipotriol)
50 mcg/g ointment (30g tube) Pack of 30
£5.78PCT FORMULARY STATUS: First Line Drugs Preparations For PsoriasisView BNF Article on 'Calcipotriol Ointment'View SPC on 'Calcipotriol Ointment'View PIL on 'Calcipotriol Ointment'
Cocois Scalp Ointment
40 g Unit Pack of 40
£6.22PCT FORMULARY STATUS: First Line Drugs Preparations For Psoriasis
View BNF Article on 'Cocois Scalp Ointment'View SPC on 'Cocois Scalp Ointment'View PIL on 'Cocois Scalp Ointment'
Coal Tar Lotion (Exorex)
5 % Lotion in emollient Pack of 100
£8.11PCT FORMULARY STATUS: First Line Drugs Preparations For PsoriasisView BNF Article on 'Coal Tar Lotion'View SPC on 'Coal Tar Lotion'View PIL on 'Coal Tar Lotion'
Calcitriol ointment (Silkis)
3 mcg/g 100g Pack of 100
£18.06PCT FORMULARY STATUS: First Line Drugs Preparations For PsoriasisView BNF Article on 'Calcitriol ointment'View SPC on 'Calcitriol ointment'View PIL on 'Calcitriol ointment'
Calcipotriol / Betamethasone (Enstilar)
60 gm 50 mcg & 0.5mg / g foam Pack of 60
£39.68PCT FORMULARY STATUS: First Line Drugs [Notes:] Enstilar foam is accepted onto the formulary as another formulation of calcipotriol and betamethasone dipropionate for patients with non-scalp psoriasis. The recommended treatment period for foam (and Dovobet ointment) is 4 weeks. If it is necessary to continue or restart treatment after this period, treatment should be continued after medical review and under regular medical supervision. General measures such as the frequent use of emollients are important in the management of psoriasis. If using other topical products containing calcipotriol in addition to Enstilar, the total dose of all calcipotriol containing products should not exceed 15 g per day. Preparations For PsoriasisView BNF Article on 'Calcipotriol / Betamethasone'View SPC on 'Calcipotriol / Betamethasone'View PIL on 'Calcipotriol / Betamethasone'
Enstilar foam is accepted onto the formulary as another formulation of calcipotriol and betamethasone dipropionate for patients with non-scalp psoriasis. The recommended treatment period for foam (and Dovobet ointment) is 4 weeks. If it is necessary to continue or restart treatment after this period, treatment should be continued after medical review and under regular medical supervision. General measures such as the frequent use of emollients are important in the management of psoriasis. If using other topical products containing calcipotriol in addition to Enstilar, the total dose of all calcipotriol containing products should not exceed 15 g per day.
Coal Tar Scalp Ointment (Sebco)
12 % solution Pack of 40
£6.20PCT FORMULARY STATUS: Second Line Drugs Preparations For PsoriasisView BNF Article on 'Coal Tar Scalp Ointment'View SPC on 'Coal Tar Scalp Ointment'View PIL on 'Coal Tar Scalp Ointment'
Calcipotriol / Betamethasone
50 mcg & 0.5mg / g oint Pack of 30
£9.30PCT FORMULARY STATUS: Second Line Drugs Preparations For PsoriasisView BNF Article on 'Calcipotriol / Betamethasone'View SPC on 'Calcipotriol / Betamethasone'View PIL on 'Calcipotriol / Betamethasone'
Calcipotriol / Betamethasone
50 mcg & 0.5mg / g gel Pack of 60
£21.21PCT FORMULARY STATUS: Second Line Drugs Preparations For PsoriasisView BNF Article on 'Calcipotriol / Betamethasone'View SPC on 'Calcipotriol / Betamethasone'View PIL on 'Calcipotriol / Betamethasone'
Puvasoralen
1.2 % Bath Lotion Pack of 1
- PCT FORMULARY STATUS: Hospital Only Drugs Preparations For PsoriasisView BNF Article on 'Puvasoralen'View SPC on 'Puvasoralen'View PIL on 'Puvasoralen'
Puvasoralen
8 emulsion 0.15% 50mL Pack of 1
- PCT FORMULARY STATUS: Hospital Only Drugs Preparations For PsoriasisView BNF Article on 'Puvasoralen'View SPC on 'Puvasoralen'View PIL on 'Puvasoralen'
Acitretin Capsule (Neotigason)
10 mg cap Pack of 60
- PCT FORMULARY STATUS: Hospital Only Drugs Preparations For PsoriasisView BNF Article on 'Acitretin Capsule'View SPC on 'Acitretin Capsule'View PIL on 'Acitretin Capsule'
Acitretin Capsule (Neotigason)
25 mg cap Pack of 60
- PCT FORMULARY STATUS: Hospital Only Drugs Preparations For PsoriasisView BNF Article on 'Acitretin Capsule'View SPC on 'Acitretin Capsule'View PIL on 'Acitretin Capsule'

 
© Kernow Clinical Commissioning Group 2024 - All Rights Reserved
The Sedgemoor Centre, Priory Road, St Austell, Cornwall, PL25 5AS